29-10-2019 14:10 via salesandmarketingnetwork.com

Soliton's Recent Positive Data Increases Potential Fibrotic Indications

HOUSTON, Oct. 29, 2019 -- (Healthcare Sales & Marketing Network)-- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of T...Devices, Dermatology
Soliton, Rapid Acoustic Pulse, Fibrotic Scar
Read more »